All updates
All updates
today 241中文产业新闻Chinese source评分6565 中文产业新闻精选Chinese source评分7373 百时美施贵宝 RYZ101 三期 ACTION-1 治疗 GEP-NETs 达 PFS 主要终点
中文产业新闻精选Chinese source评分7373 国家药监局批准佰仁医疗经导管肺动脉瓣膜系统创新医疗器械上市
中文产业新闻精选Chinese source评分7575 三生制药紫杉醇口服溶液（柏瑞素）乳腺癌适应症获NMPA批准
中文产业新闻Chinese source评分6161 小核酸公司 ADARx IPO 募资约 40 亿元，艾伯维参与同步私募配售
中文产业新闻Chinese source评分1919 过敏是免疫与神经的"双重奏"
中文产业新闻精选Chinese source评分8484 EPCORE DLBCL-2 III期：艾可瑞妥单抗联合R-CHOP显著改善初治DLBCL患者PFS
中文产业新闻Chinese source评分6464 艾伯维 D1/D5 受体部分激动剂 Tavapadon 获 FDA 批准用于成人帕金森病
中文产业新闻Chinese source评分7070 BMS核药RYZ101三期ACTION-1研究达PFS主要终点，市值盘前涨超400亿元
中文产业新闻Chinese source评分6060 香港 CMPR 首任掌门人落定，李自力获委任任期三年
BioSpace评分3838 Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings
Nature评分3535 Daily briefing: Visit a huge climate experiment in the Amazon rainforest
Nature Medicine评分5757 Human–artificial intelligence collaboration for comanaging epilepsy in real time
Nature Medicine评分5252 Autologous and broadly neutralizing antibodies drive ART-free HIV control
Nature Medicine精选评分6666 Characterizing the onset and progression of cancer cachexia using routine clinical data
Nature Genetics评分5252 Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression
STAT News精选评分5656 STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
Nature评分3131 In the AI era, coding means thinking like a systems architect
中文产业新闻Chinese source评分6868 罗氏以11.6亿美元引进大睿生物ALK7 siRNA全球独家权益
中文产业新闻Chinese source评分6666 全球首款实体瘤CAR-T产品在上海国际医院完成首例跨境实体瘤治疗
中文产业新闻Chinese source评分6464 大睿生物授予罗氏超 11 亿美元全球许可，基于肝外递送平台开发 ALK7 siRNA 肥胖症疗法
中文产业新闻Chinese source评分6666 史赛克 4 亿美元战略投资 CMR Surgical 并锁定未来收购选择权
监管与产业动态评分3939 What biotechnology can teach policymakers about how to regulate AI
监管与产业动态精选评分6666 Viatris adds analgesics, pipeline via Pacira takeout: Deals Report
监管与产业动态评分3939 Trio of celiac trial successes puts dosing in the spotlight
监管与产业动态评分4848 Overton confirmation battling clock, abortion politics
监管与产业动态评分3232 Biotech markets: Pause before the storm? A BioCentury podcast
中文产业新闻Chinese source评分6161 关于印发健康医疗数据流通管理办法（试行）等4个数据流通制度的通知发布
中文产业新闻Chinese source评分6262 BMS/RayzeBio RYZ101（²²⁵Ac-DOTATATE）3 期 ACTION-1 试验达到主要终点
中文产业新闻精选Chinese source评分7373 翰森制药HS-10380治疗急性精神分裂症2b期达到主要终点
中文产业新闻Chinese source评分6565 金赛药业引进甲磺酸亮丙瑞林6月长效注射液获NMPA批准，用于前列腺癌ADT
监管与产业动态评分4242 Breast cancer before 40: Younger patients face higher odds of delayed diagnosis
监管与产业动态评分22 From Data Rich to Decision Ready in Life Sciences - Fierce Pharma
监管与产业动态评分2828 Merck’s deeper dive into efficacy, safety of $1.3B eye disease drug raises fears of ‘limited’ potential - Fierce Biotech
监管与产业动态评分3131 DNA changes in Alzheimer's disease: What they mean to patients, families
监管与产业动态评分4444 Two-trigger drugs target 'zombie' cancer cells with sharper aim
监管与产业动态评分2727 How 'people power' and business transformed medicine, but created a whole new set of risks
监管与产业动态评分3737 Everyday salon tools may expose hairdressers to allergy-triggering metals
监管与产业动态评分1616 Why Medical Affairs Is Becoming Biopharma’s Third Pillar - Fierce Pharma
监管与产业动态评分88 How data is reshaping rare disease media strategy - Fierce Pharma